Fortune 40: Stock picks to retire on

Forty stock picks inspired by the greatest investors of all-time: From the deepest values to solid growth, these shares can make retirement dreams come true.

ABT: The numbers
Market Cap $83.4 billion
Total Return YTD (June 11) 12.3%
Total Return Last 12 Months 28.5%
Earnings Growth (Next Five Years) 11.0%
P/E (Pasts 12 months) 21.8
P/E (Next Year's Estimate) 16.7
Dividend Yield 2.4%
Source: Baseline, as of June 11, 2007.
Growth and Income
Abbott Labs
Abbott has its hands in several areas of health care, which will come in handy if any one area stumbles. Specifically, its stent business is growing steadily as are sales of its nutritional products (think energy bars).

In April, Abbott snipped the ribbon on a $450 million, 330,000-square foot biotech plant in Puerto Rico, a signal that the company is trying to assert itself in new growth areas.

One bit of trouble to keep an eye on: Drug-coated stents by Abbott and other drug makers are currently in the news for potential blood clot risk they pose.
Abbott Labs Johnson & Johnson Coca-Cola Altria Group Colgate General Mills Procter & Gamble Wyeth Accenture AIG Chubb ConocoPhillips McKesson 3M Microsoft United Health Pfizer Aetna Applied Industrial Carpenter Technology Loews Lufkin Tidewater VF Corp. Grey Wolf CSG Systems Hercules K-Swiss Navigant Consulting Park Electrochemical Penn Virginia Plexus UBS Diageo Novartis Petroleo Brasileiro Sanofi-Aventis Total Unilever Vodafone
Bargain hunting for condos The real estate slowdown has made parts of the Sunbelt a lot more affordable. Fortune presents a guide to finding the best deals in five markets. (more)
Retired at 50 Is it possible for someone who doesn't run a hedge fund or win the lottery to retire at 50 (or so)? Yes. (more)
Retirement: Now what?! Think you know what will make you happy? Learn from those who've been there, done that. (more)